Evolus Inc

Evolus Inc. is a US-based performance beauty company operating primarily in the United States. Its primary aim is to deliver breakthrough products in the cash-pay aesthetics market, focusing on innovative solutions for facial aesthetics. Operating within the medical aesthetics sector, it offers Jeuveau®, a proprietary neurotoxin formulation used to temporarily improve the appearance of moderate to severe frown lines in adults. The company also provides Evolysse™, a collection of injectable hyaluronic acid gels designed to address facial wrinkles and volume loss. Keep up to date on the latest share price changes by adding EOLS stock to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.